RSV

Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
Fierce Biotech
Thu, 04/7/22 - 10:29 am
Pfizer
RSV
M&A
ReViral
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
Pfizer grabs another breakthrough tag for RSV shot in older adults
Fierce Biotech
Thu, 03/24/22 - 11:05 am
Pfizer
RSV
vaccines
elderly
breakthrough designation
Moderna trains its mRNA tech on the common cold and a triple whammy against 3 respiratory diseases
Fierce Biotech
Tue, 03/22/22 - 10:49 am
Moderna Therapeutics
vaccines
MRNA
COVID-19
RSV
Flu
mRNA-1230
common cold
mRNA-1287
Small RSV contender eyes 'first-to-market' opportunity with $225M Asia deal
Endpoints
Mon, 03/21/22 - 10:13 am
Bavarian Nordic
RSV
vaccines
Asia
Nuance Pharma
Glaxo holds its breath
EP Vantage
Thu, 03/17/22 - 10:17 am
GSK
RSV
vaccines
elderly
clinical trials
Sanofi, AstraZeneca Express Optimism Over Phase III Infant RSV Results
BioSpace
Thu, 03/3/22 - 10:24 am
Sanofi
AstraZeneca
nirsevimab
vaccines
RSV
clinical trials
Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag
Fierce Biotech
Wed, 03/2/22 - 12:16 pm
Pfizer
GSK
vaccines
RSV
PF-06482077
FDA
breakthrough status
GSK halts RSV vaccine trials in pregnant women after pause
Pharmaforum
Mon, 02/28/22 - 11:40 am
GSK
clinical trials
RSV
vaccines
pregnancy
Moderna begins late-stage study of RSV vaccine using mRNA technology
Yahoo/Reuters
Tue, 02/22/22 - 10:39 am
Moderna Therapeutics
vaccines
MRNA
RSV
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
Fierce Biotech
Fri, 02/18/22 - 10:37 am
GSK
Pfizer
RSV
vaccines
clinical trials
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT
Fierce Pharma
Tue, 02/8/22 - 11:57 pm
JNJ
vaccines
COVID-19
RSV
drug manufacturing
J&J squares up to Big Pharma rivals with extra RSV vaccine data
Fierce Biotech
Tue, 12/7/21 - 10:56 am
JNJ
vaccines
RSV
Pfizer
GSK
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Wed, 12/1/21 - 11:46 pm
Sanofi
vaccines
RSV
Flu
MRNA
pneumococcal disease
RSVVW 2021 – Pfizer gets maternal
EP Vantage
Mon, 11/1/21 - 11:01 pm
Pfizer
RSV
vaccines
RSVpreF
RSVVW
Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine
Motley Fool
Tue, 10/19/21 - 10:45 am
JNJ
RSV
vaccines
clinical trials
J&J heats up RSV race with new vaccine data
BioPharma Dive
Mon, 10/4/21 - 10:58 pm
JNJ
RSV
vaccines
clinical trials
Could This Be Pfizer's Next Blockbuster Vaccine?
Motley Fool
Fri, 09/10/21 - 11:00 am
Pfizer
vaccines
RSV
RSVpreF
clinical trials
GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail
Endpoints
Tue, 09/7/21 - 12:03 pm
GSK
JNJ
Pfizer
Bavarian Nordic
Moderna Therapeutics
RSV
vaccines
Pfizer, marking fast research pace, starts key trial of RSV vaccine
BioPharma Dive
Thu, 09/2/21 - 09:59 pm
Pfizer
clinical trials
RSV
vaccines

Pages